ACCC’s new podcast, CANCER BUZZ, features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is conversation that unpacks the issues and sparks insight. Where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.
Learn about ACCC's efforts to make the case for hiring comprehensive care team members, as well as the development of a matrix tool to help programs prepare for alternative payment models.
We sit down with journalist Mary Elizabeth Williams, one of the first patients treated with combination immunotherapy, to discuss her experience as an IO patient and how to bridge communication gaps among patients, doctors, and researchers.
We talk to a medical oncologist in a rural Montana community about the realities of rural cancer care, the importance of community oncology, and how he navigates common barriers to quality care.
Guest: Chad Pedersen, MD, Medical Oncologist, Sidney Health Center
Learn why a trip to the emergency department is different for patients who receive immunotherapy for cancer, what information helps ED clinicians, and what busy emergency department providers need to know about immune-related adverse events.
Learn how a rural health system harnessed its passion and creativity to work around obstacles to clinical trial access and ensure its patients have access to cutting-edge cancer treatments.
Guest: Lora Black, RN, MPH, OCN, CCRP, Senior Director, Clinical Research, Sanford Research; Clinical Instructor, Sanford School of Medicine at the University of South Dakota; Core Director, Clinical Research Resources and Facilities Core, DaCCoTA CTR
Learn more about the challenges to cancer care delivery in rural settings, and discover some of the innovative ways that they are working to better serve this at-risk patient population.
Guest: Jack Hensold, MD, Medical Oncologist, Bozeman Health Cancer Center; President, Montana State Oncology Society
Learn about the transition from immunotherapy into post-treatment survivorship, how it differs from chemotherapy, and why coordination and communication among providers, patients, and caregivers is essential.